Akebia Ther
Price & Volume
Stats
See more52W Range | $0.80-$2.48 |
Market Cap | $421M |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $169.8M |
Revenue Growth (YoY) | -11% |
Gross Profit (12 Mos) | $140M |
Diluted EPS | -$0.22 |
News
See moreYahoo Finance • last year
Akebia Therapeutics to Present at Piper Sandler Healthcare Conference
Yahoo Finance • last year
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q3 2023 Earnings Call Transcript
Yahoo Finance • 2 years ago
Akebia Announces Swissmedic Approval of Vafseo® (vadadustat)
Yahoo Finance • 2 years ago
Akebia Therapeutics to Report Second Quarter Financial Results
About
CEO | Mr. John P. Butler MBA |
CFO | Mr. Erik John Ostrowski M.B.A. |
Address | 245 First Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 167 |
